Pharmaceutical firm GlaxoSmithKline (GSK) has confirmed job losses at one of its UK sites.
It is believed about 200 roles will be cut at the facility in Barnard Castle, County Durham, in October 2025.
The team affected has been producing the antibiotic Zinnat for the Swiss-owned firm Sandoz.
GSK said the vast majority of its staff at Barnard Castle were unaffected and that its first priority was to provide “comprehensive support” for those impacted.
The firm had said in 2021 that its Zinnat operations would be terminated when its contract with Sandoz ended “in the absence of any other alternative”.
It has now confirmed Sandoz has decided not to renew its contract.
The move comes as GSK confirmed it was shutting its site at Ulverston, Cumbria, which has also been producing the antibiotic for Sandoz.
A GSK spokesperson said Barnard Castle remained a key location where it manufactured some of its most “innovative medicines”.
Pn 20th September 2024 Timothy Graham Vance, Alan Michael Hudson and Dan Edkins of EY-Parthenon were appointed as joint administrators to eight UK trading ent
By Jessica Clark Published: 23:54 BST, 20 September 2024 | Updated: 00:08 BST, 21 September 2024
ONE of the UK’s biggest prison-builders has collapsed into administration.ISG — which has more than £1billion of government contracts — is the largest UK
Closure of the blast furnaces will lead to far more job losses than thoughtDeal between Tata Steel and Labour will see more than 4,000 workers axed